Comparison of Dako HercepTest and Ventana PATHWAY anti-HER2 (4B5) tests and their correlation with silver in situ hybridization in lung adenocarcinoma

Discordant results exist about the role of human epidermal growth factor receptor 2 (HER2) overexpression and/or HER2 amplification in lung adenocarcinoma. We aimed to compare the performance of HercepTest and PATHWAY anti-HER2 (4B5) by correlating immunohistochemistry (IHC) results with silver in s...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Miladinović Mirjana, Vučković Ljiljana, Klisic Aleksandra
Formato:	article
Lenguaje:	EN
Publicado:	De Gruyter 2021
Materias:	adenocarcinoma amplification her2 ihc lung Medicine R
Acceso en línea:	https://doaj.org/article/5f7c00daba9c4f91a24722282c2aff61
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:5f7c00daba9c4f91a24722282c2aff61
record_format	dspace
spelling	oai:doaj.org-article:5f7c00daba9c4f91a24722282c2aff612021-12-05T14:10:55ZComparison of Dako HercepTest and Ventana PATHWAY anti-HER2 (4B5) tests and their correlation with silver in situ hybridization in lung adenocarcinoma2391-546310.1515/med-2021-0366https://doaj.org/article/5f7c00daba9c4f91a24722282c2aff612021-10-01T00:00:00Zhttps://doi.org/10.1515/med-2021-0366https://doaj.org/toc/2391-5463Discordant results exist about the role of human epidermal growth factor receptor 2 (HER2) overexpression and/or HER2 amplification in lung adenocarcinoma. We aimed to compare the performance of HercepTest and PATHWAY anti-HER2 (4B5) by correlating immunohistochemistry (IHC) results with silver in situ hybridization (SISH) in adenocarcinoma lung specimens.Miladinović MirjanaVučković LjiljanaKlisic AleksandraDe Gruyterarticleadenocarcinomaamplificationher2ihclungMedicineRENOpen Medicine, Vol 16, Iss 1, Pp 1503-1512 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	adenocarcinoma amplification her2 ihc lung Medicine R
spellingShingle	adenocarcinoma amplification her2 ihc lung Medicine R Miladinović Mirjana Vučković Ljiljana Klisic Aleksandra Comparison of Dako HercepTest and Ventana PATHWAY anti-HER2 (4B5) tests and their correlation with silver in situ hybridization in lung adenocarcinoma
description	Discordant results exist about the role of human epidermal growth factor receptor 2 (HER2) overexpression and/or HER2 amplification in lung adenocarcinoma. We aimed to compare the performance of HercepTest and PATHWAY anti-HER2 (4B5) by correlating immunohistochemistry (IHC) results with silver in situ hybridization (SISH) in adenocarcinoma lung specimens.
format	article
author	Miladinović Mirjana Vučković Ljiljana Klisic Aleksandra
author_facet	Miladinović Mirjana Vučković Ljiljana Klisic Aleksandra
author_sort	Miladinović Mirjana
title	Comparison of Dako HercepTest and Ventana PATHWAY anti-HER2 (4B5) tests and their correlation with silver in situ hybridization in lung adenocarcinoma
title_short	Comparison of Dako HercepTest and Ventana PATHWAY anti-HER2 (4B5) tests and their correlation with silver in situ hybridization in lung adenocarcinoma
title_full	Comparison of Dako HercepTest and Ventana PATHWAY anti-HER2 (4B5) tests and their correlation with silver in situ hybridization in lung adenocarcinoma
title_fullStr	Comparison of Dako HercepTest and Ventana PATHWAY anti-HER2 (4B5) tests and their correlation with silver in situ hybridization in lung adenocarcinoma
title_full_unstemmed	Comparison of Dako HercepTest and Ventana PATHWAY anti-HER2 (4B5) tests and their correlation with silver in situ hybridization in lung adenocarcinoma
title_sort	comparison of dako herceptest and ventana pathway anti-her2 (4b5) tests and their correlation with silver in situ hybridization in lung adenocarcinoma
publisher	De Gruyter
publishDate	2021
url	https://doaj.org/article/5f7c00daba9c4f91a24722282c2aff61
work_keys_str_mv	AT miladinovicmirjana comparisonofdakoherceptestandventanapathwayantiher24b5testsandtheircorrelationwithsilverinsituhybridizationinlungadenocarcinoma AT vuckovicljiljana comparisonofdakoherceptestandventanapathwayantiher24b5testsandtheircorrelationwithsilverinsituhybridizationinlungadenocarcinoma AT klisicaleksandra comparisonofdakoherceptestandventanapathwayantiher24b5testsandtheircorrelationwithsilverinsituhybridizationinlungadenocarcinoma
_version_	1718371607052812288

Comparison of Dako HercepTest and Ventana PATHWAY anti-HER2 (4B5) tests and their correlation with silver in situ hybridization in lung adenocarcinoma

Ejemplares similares